Great to see my #review on #pharmacogenomics in @NatureRevGenet. rdcu.be/c4iur
@BritPharmSoc @LivUni @pandtuol @CDSS_Liverpool @pgrnhub @pharmgkb @nwgmsa @LivUniISMIB
Key messages:
@BritPharmSoc @LivUni @pandtuol @CDSS_Liverpool @pgrnhub @pharmgkb @nwgmsa @LivUniISMIB
Key messages:
A. Wider definition of #pharmacogenomics
B. Pharmacogenomic #variation is common, we are exposed to many #drugs which require pharmacogenomic #guidance
C. There is increasing #evidence of #clinical #utility of #PGx
B. Pharmacogenomic #variation is common, we are exposed to many #drugs which require pharmacogenomic #guidance
C. There is increasing #evidence of #clinical #utility of #PGx
D. We need more studies on #diversity in #PGx
E. The time is right for #implementation of #PGx #personalised #prescribing
bps.ac.uk/getmedia/b43a3…
E. The time is right for #implementation of #PGx #personalised #prescribing
bps.ac.uk/getmedia/b43a3…
F. Great opportunities in #drug #discovery and #development
G. Many exciting avenues for #research in #pharmacogenomics through #biobanks, rare variants, #polygenic risk scores
G. Many exciting avenues for #research in #pharmacogenomics through #biobanks, rare variants, #polygenic risk scores
H. Ultimately, we need to combine #PGx variation with #clinical factors determining #variability in drug #response into multimodal #Algorithms
• • •
Missing some Tweet in this thread? You can try to
force a refresh
